• 1
    Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev 2011; 27:313.
  • 2
    Kondrashova A, Reunanen A, Romanov A et al. A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 2005; 37:6772.
  • 3
    Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 2008; 34:53748.
  • 4
    Jaïdane H, Sane F, Gharbi J, Aouni M, Romond MB, Hober D. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab Res Rev 2009; 25:591603.
  • 5
    Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev Med Virol 2010; 20:26580.
  • 6
    Hober D, Sane F. Enteroviruses and type 1 diabetes. BMJ 2011; 342:c7072.
  • 7
    Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011; 342:d35.
  • 8
    Stene LC, Rewers M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies. Clin Exp Immunol 2012; 168:1223.
  • 9
    Lind K, Hühn MH, Flodström-Tullberg M. Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes. Clin Exp Immunol 2012; 168:308.
  • 10
    Hober D, Sane F. Enteroviral pathogenesis of type 1 diabetes. Discov Med 2010; 10:15160.
  • 11
    Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010; 6:27989.
  • 12
    Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19:8094.
  • 13
    Tauriainen S, Oikarinen S, Oikarinen M, Hyoty H. Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 2011; 33:4555.
  • 14
    Sane F, Moumna I, Hober D. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes. Exp Rev Clin Immunol 2011; 7:35766.
  • 15
    Sauter P, Hober D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect 2009; 11:44351.
  • 16
    Baxt B, Mason PW. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor-mediated adsorption. Virology 1995; 207:5039.
  • 17
    Girn J, Kavoosi M, Chantler J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J Gen Virol 2002; 83:3518.
  • 18
    Kishimoto C, Kurokawa M, Ochiai H. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J Mol Cell Cardiol 2002; 34:122738.
  • 19
    Chehadeh W, Weill J, Vantyghem MC et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection. J Infect Dis 2000; 181:192939.
  • 20
    Coppieters KT, Wiberg A, Tracy SM, von Herrath MG. Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol 2012; 168:511.
  • 21
    Chehadeh W, Bouzidi A, Alm G, Wattre P, Hober D. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro. J Gen Virol 2001; 82:1899907.
  • 22
    Hober D, Chehadeh W, Weill J et al. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes. J Gen Virol 2002; 83:216976.
  • 23
    Hober D, Chehadeh W, Bouzidi A, Wattre P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis. J Infect Dis 2001; 184:1098108.
  • 24
    Chehadeh W, Lobert PE, Sauter P et al. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J Virol 2005; 79:1388291.
  • 25
    Sauter P, Lobert PE, Lucas B et al. Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells. Virus Res 2007; 125:18390.
  • 26
    Sauter P, Chehadeh W, Lobert PE et al. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. J Med Virol 2008; 80:86678.
  • 27
    Muckelbauer JK, Kremer M, Minor I et al. Structure determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystallogr D Biol Crystallogr 1995; 51:87187.
  • 28
    Li Q, Yafal AG, Lee YM, Hogle J, Chow M. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature. J Virol 1994; 68:396570.
  • 29
    Goffard A, Sane F, Soumillon M, Hober D. Specificity of the coxsackievirus B4 VP4 capsid protein investigated in silico. Discov Med 2011; 12:1538.
  • 30
    Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ. Induction of type 1 diabetes by interferon-α in transgenic mice. Science 1993; 260:194246.
  • 31
    Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5:21926.
  • 32
    Grieco F, Sebastiani G, Spagnuolo I, Patti A, Dotta F. How viral infections modulate beta-cell function. Clin Exp Immunol 2012; 168:249.
  • 33
    Kanno T, Kim K, Kono K, Drescher KM, Chapman NM, Tracy S. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency. J Virol 2006; 80:563743.
  • 34
    Hyoty H. Enterovirus infections and type 1 diabetes. Ann Med 2002; 34:13847.
  • 35
    Prince GA, Jenson AB, Hemming VG et al. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J Virol 1986; 57:72128.
  • 36
    Gimenez HB, Keir HM, Cash P. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera. J Gen Virol 1989; 70:8996.